---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-015291"
form_type: "8-K"
ticker: "PBYI"
cik: "0001401667"
company_name: "PUMA BIOTECHNOLOGY, INC."
filed_at: "2022-06-17T23:59:59+00:00"
generated_at: "2026-06-25T00:47:37.589190+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Puma Biotechnology shareholders elect directors, ratify KPMG, approve say-on-pay at 2022 annual meeting

## Summary
- All seven director nominees elected: Auerbach (29.9M for, 0.9M withheld), Wilson (20.4M for, 10.4M withheld).
- KPMG ratified as independent auditor for FY2022 with 37.1M votes for, 0.5M against, 0.1M abstain.
- Advisory vote on executive compensation approved: 27.1M for, 3.6M against, 0.1M abstain, with 6.95M broker non-votes.
- Meeting held June 14, 2022; all proposals passed with broker non-votes on director and say-on-pay proposals.

## SEC filing metadata
- accession: 0001437749-22-015291
- form_type: 8-K
- ticker: PBYI
- cik: 0001401667
- company_name: PUMA BIOTECHNOLOGY, INC.
- filed_at: 2022-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401667/000143774922015291/0001437749-22-015291-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401667/000143774922015291/pbyi20220616_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-015291
- JSON: https://secwatch.observer/filing/0001437749-22-015291.json
- Plain text: https://secwatch.observer/filing/0001437749-22-015291.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.